glp-1 and alzheimer's disease improves the neuronal supportive ability of astrocytes in by regulating mitochondrial dysfunction via the cAMP/PKA pathway Role of glucagon-like peptide-1 receptor

As a monogenic disease, ATTR amyloidosis represents an ideal target for in vivo gene editing mediated by CRISPR-Cas9

When to Avoid Combining These Therapies Certain medical conditions warrant caution or contraindication

Tuy nhin, khi s dng dng thuc ung, Tt nht bn nn tham kho kin ca bc s xc nh xem n c ph hp vi mnh hay khng

Given their adverse side effect profile, they should be reserved for a select group of patients in whom medications with cardiovascular benefit, discussed below, are not an option

Talk to our experts and get a personalized plan today Lets Talk

Natural compounds such as polydatin, naringenin, or proanthocyanidins are pharmacologically appealing because of their multi-target anti-inflammatory effects, but they also face familiar barriers of low oral bioavailability, uncertain pancreas exposure, and limited pharmacokinetic standardization